Global Veterinary Diagnostic Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Veterinary diagnostics is the process of identifying and determining the nature or cause of diseases in animals. It plays a crucial role in veterinary medicine by helping veterinarians make informed decisions about the health and treatment of animals. Diagnostic tests in veterinary medicine are designed to detect the presence of pathogens, abnormalities, or other health-related conditions. These tests can be applied to a variety of animals, including pets, livestock, and wildlife. The key factors driving the market growth are the growing adoption of pet ownership, rising animal health expenditure, the growing burden of animal zoonotic diseases, and rising Prevalence of Animal Diseases that are anticipated to support the market growth during the projected period 2023-2030.
Additionally, rising pet ownership and the growing human-animal bond have led to an increased demand for veterinary services, including diagnostics. According to the 2021-2022 APPA National Pet Owners Survey, the number of U.S. households that own cats is 45.3 million, Dog 69 million, Hours 3.5 million, Reptile is 5.7 million and small animals are 6.2 million. As a result, the growing pet ownership is anticipated to support the market growth. Moreover, growing veterinary healthcare spending and growing number of veterinary practitioners is anticipated to create a lucrative opportunity for the market over the projected period. However, the high cost of veterinary diagnostic tests stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Veterinary Diagnostic Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing pet ownership, rising animal diseases, growing advancements in diagnostic technologies, and rising veterinary healthcare spending. Whereas, the Asia Pacific is expected to grow with the highest CAGR over the forecast period, owing to factors such as the growing awareness about zoonotic diseases and increased pet expenditure, increasing demand for livestock, growing Point-of-Care Testing (POCT) adoption, and rising prevalence of animal diseases.
Major market player included in this report are:
IDEXX Laboratories, Inc. (U.S.)
Zoetis Services LLC (U.S.)
Heska Corporation (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Avante Animal Health (U.S.)
Virbac (France)
Randox Laboratories Ltd. (U.K.)
VCA Animal Hospitals (Mars, Incorporated) (U.S.)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Bio-Rad Laboratories Inc. (US)
Recent Developments in the Market:
Ø In July 2022, BioNote USA joined forces with PSIvet in an exciting partnership aimed at enhancing affordability for BioNote’s Vcheck line of analyzers and tests. This collaboration is set to benefit over 5,000 veterinary practices associated with PSIvet, making cutting-edge diagnostic solutions more accessible.
Global Veterinary Diagnostic Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product Type, Technique, Animal Type, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Instruments
Reagents & Consumables
By Technique:
Hematology
Immunodiagnostics
Molecular Diagnostics
Diagnostic Imaging
Clinical Biochemistry
Others
By Animal Type:
Livestock
Companion
By End User:
Veterinary Hospitals & Clinics
Veterinary Reference Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa